Humanized antibodies to .gamma.-interferon
US6329511A · kind A · utility
127Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 29, 1999 |
| Grant date | Dec 11, 2001 |
| Priority date | — |
| Expiry date | Nov 29, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides humanized immunoglobulins that bind to and neutralize .gamma.-interferon. The antibodies are useful for treatment of diseases of the immune system, particularly autoimmune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.